Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy.

Literature DB >> 29387870

Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy.

Sa Rang Kim¹, Henry Heaton¹, Lucy Y Liu¹, Brett A King¹.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2018 PMID： 29387870 DOI： 10.1001/jamadermatol.2017.5778

Source DB: PubMed Journal: JAMA Dermatol ISSN： 2168-6068 Impact factor: 10.282

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Effective use of oral tofacitinib and phototherapy in a patient with concomitant alopecia areata, vitiligo, and plaque and inverse psoriasis.

Authors: Mahroo Tajalli; Soodeh Kabir; Terrence M Vance; Abrar A Qureshi
Journal: Clin Case Rep Date: 2020-02-27

Review 2. Targeting the Janus Kinase Family in Autoimmune Skin Diseases.

Authors: Michael D Howell; Fiona I Kuo; Paul A Smith
Journal: Front Immunol Date: 2019-10-09 Impact factor: 7.561

Review 3. Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata.

Authors: Ana M Montilla; Francisco Gómez-García; Pedro J Gómez-Arias; Jesús Gay-Mimbrera; Jorge Hernández-Parada; Beatriz Isla-Tejera; Juan Ruano
Journal: Dermatol Ther (Heidelb) Date: 2019-10-13

Review 4. Vitiligo, From Physiopathology to Emerging Treatments: A Review.

Authors: Laure Migayron; Katia Boniface; Julien Seneschal
Journal: Dermatol Ther (Heidelb) Date: 2020-09-19

Review 5. Translational Research in Vitiligo.

Authors: Erica L Katz; John E Harris
Journal: Front Immunol Date: 2021-03-02 Impact factor: 7.561

Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy.

1. Effective use of oral tofacitinib and phototherapy in a patient with concomitant alopecia areata, vitiligo, and plaque and inverse psoriasis.

Review 2. Targeting the Janus Kinase Family in Autoimmune Skin Diseases.

Review 3. Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata.

Review 4. Vitiligo, From Physiopathology to Emerging Treatments: A Review.

Review 5. Translational Research in Vitiligo.

Review 6. The Promising Role of Chemokines in Vitiligo: From Oxidative Stress to the Autoimmune Response.

Review 7. Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.

Review 8. Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments.

Review 9. Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.

10. Partial repigmentation of vitiligo with tofacitinib, without exposure to ultraviolet radiation.